ClinVar Miner

Submissions for variant NM_014845.5(FIG4):c.1666dup (p.Thr556fs) (rs772320287)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Clinical Services Laboratory,Illumina RCV000330403 SCV000459626 likely pathogenic FIG4-Related Disorders 2016-06-14 criteria provided, single submitter clinical testing The c.1666dup (p.Thr556AsnfsTer20) results in a frameshift, and is predicted to result in premature termination of the protein. The p.Thr556AsnfsTer20 variant has been reported in one study in two patients with Charcot-Marie-Tooth disease in a compound heterozygous state with a missense variant (Nicholson et al. 2011). No publications were found for this variant in relation to autosomal dominant amyotrophic lateral sclerosis. The p.Thr556AsnfsTer20 variant was absent from 206 controls and is not found in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium. Due to the potential impact of frameshift variants, the p.Thr556AsnfsTer20 variant is classified as likely pathogenic for FIG4-related disorders.
Invitae RCV000798693 SCV000938320 pathogenic Charcot-Marie-Tooth disease type 4 2019-10-10 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Thr556Asnfs*21) in the FIG4 gene. It is expected to result in an absent or disrupted protein product. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has been observed in individuals affected with autosomal recessive Charcot-Marie-Tooth disease (PMID: 21705420). ClinVar contains an entry for this variant (Variation ID: 355040). Loss-of-function variants in FIG4 are known to be pathogenic (PMID: 23623387). For these reasons, this variant has been classified as Pathogenic.
Athena Diagnostics Inc RCV000991993 SCV001143926 pathogenic not provided 2019-07-16 criteria provided, single submitter clinical testing The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Found in at least one symptomatic patient, and found in general population data that is consistent with pathogenicity.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.